BRCA1 promoter methylation is a marker of better response to platinum–taxane-based therapy in sporadic epithelial ovarian cancer
Crossref DOI link: https://doi.org/10.1007/s00432-014-1704-5
Published Online: 2014-05-14
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ignatov, T.
Eggemann, H.
Costa, S. D.
Roessner, A.
Kalinski, T.
Ignatov, A.
Text and Data Mining valid from 2014-05-14